腹腔疾病藥物全球市場規模調查和預測，按藥物（一線、二線）、區域分析，2022-2029 年

乳糜瀉、口炎性腹瀉和麩質敏感性腸病是影響小腸的消化系統疾病。

攝入麩質會觸發小腸的免疫反應。 腹腔疾病有多種症狀，包括腹瀉、腹脹、風、疲勞、低血細胞計數（貧血）和骨質疏鬆症。 乳糜瀉患病率的增加，增加對乳糜瀉意識計劃的投資是推動市場增長的關鍵因素。

乳糜瀉患病率的增加促進了全球乳糜瀉治療市場的擴大。 例如，Beyond Celiac Organization 估計，美國每 133 人中就有 1 人（約佔人口的 1%）患有乳糜瀉。 根據芝加哥大學醫學院乳糜瀉中心的估計，乳糜瀉影響了美國至少 300 萬美國人。 此外，預計在預測期內，新興地區對醫療保健行業投資的增加以及乳糜瀉藥物研發活動的增加將為市場提供良好的增長前景。 然而，嚴格的藥品審批監管框架阻礙了整個 2022-2029 年預測期內的市場增長。

乳糜瀉藥物全球市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於品牌產品的主導地位和該地區腹腔疾病發病率的增加，北美在收入方面佔據了市場主導地位。 另一方面，由於老年人口和目標人群的增加以及醫療保健行業的增長等因素，預計亞太地區在預測期內將以最高的複合年增長率增長。

市場近期發展

• 2019 年 8 月，美國食品藥品監督管理局 (FDA) 批准了 ActoBio Therapeutics 的口服 ActoBiotics AG017 膠囊的新藥研究 (IND)。 這種新藥是治療乳糜瀉的口服生物候選藥物。

全球市場報告範圍

• 歷史數據：2019-2020-2021
• 估算基準年：2021 年
• 預測期：2022-2029
• 報告範圍：收入預測、公司排名、競爭格局、增長因素、趨勢
• 按地區劃分：北美、歐洲、亞太地區、拉丁美洲、世界其他地區
• 定制範圍：免費報告定制（最多 8 個工作小時）。 按國家、地區和部門劃分的範圍的添加和更改。

本研究的目的是弄清近年來各個領域和國家的市場規模，並對未來幾年的市場規模進行預測。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還結合了利益相關者投資的潛在微觀市場機會，以及主要參與者的競爭格局等詳細分析。

內容

第 1 章執行摘要

• 市場概況
• 2019-2029 年各細分市場的全球市場估計和預測
  • 2019-2029 年各地區乳糜瀉藥物市場
  • 乳糜瀉藥物市場，按藥物分類，2019-2029 年
• 主要趨勢
• 調查方法
• 調查先決條件

第 2 章乳糜瀉藥物全球市場的定義和範圍

• 調查目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 本次調查涵蓋的年份
• 貨幣兌換率

第三章乳糜瀉藥物的全球市場動態

• 腹腔藥物市場影響分析 (2019-2029)
  • 市場驅動因素
    • 乳糜瀉的發病率增加
    • 擴大對乳糜瀉宣傳計劃的投資
  • 市場挑戰
    • 嚴格的藥品審批監管框架
  • 市場機會
    • 增加對新興國家/地區醫療保健行業的投資
    • 啟動與乳糜瀉治療藥物相關的研發活動

第四章乳糜瀉藥物全球市場行業分析

• 波特 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 波特 5 力模型的未來方法 (2019-2029)
• 害蟲分析
  • 政治
  • 經濟的
  • 社交
  • 技術
• 最佳投資機會
• 關鍵成功策略
• 業內人士的前景
• 分析師的建議和結論

第 5 章風險評估 COVID-19 影響

• 評估 COVID-19 對行業的總體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章乳糜瀉藥物的全球市場：按藥物分類

• 市場概況
• 乳糜瀉藥物的全球市場：藥物和性能的潛力分析
• 2019-2029 年乳糜瀉藥物全球市場估計和預測
• 乳糜瀉藥物市場細分分析
  • 一線治療
  • 二線治療

第 7 章全球乳糜瀉藥物市場：區域分析

• 乳糜瀉藥物市場，按地區劃分的市場概況
• 北美
  • 美國
    • 2019-2029 年各藥物的估計和預測
  • 加拿大
• 歐洲乳糜瀉藥物市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲
• 亞太地區乳糜瀉藥物市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲乳糜瀉藥物市場概況
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地區
• 世界其他地方

第 8 章衝突信息

• 頂級市場策略
• 公司簡介
  • F. Hoffmann La Roche
    • 關鍵信息
    • 概覽
    • 財務（僅當數據可用時）
    • 產品概述
    • 近期趨勢
  • Merck & Co., Inc.
  • Johnson & Johnson
  • BiolineRx Ltd.
  • Pfizer Inc.
  • Innovate Biopharmaceuticals
  • ImmusanT, Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Immunomedics, Inc.

第九章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場評估
  • 驗證
  • 出版
• 調查的特點
• 調查先決條件

Global Celiac Disease Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Celiac Disease or celiac sprue or gluten-sensitive enteropathy is a digestive problem that affects small intestine. Consumption of gluten triggers an immune response in the small intestine. There are different symptoms of Celiac disease including diarrhoea, bloating, wind, fatigue, low blood count (anaemia) and osteoporosis among others. The increasing incidence of Celiac Disease and growing investments in celiac disease awareness programs are key factors driving the market growth.

The increasing prevalence of Celiac Disease is contributing towards the expansion of Global Celiac Disease Treatment Market. For instance - as per Beyond Celiac Organization - in the United States an estimated 1 in 133 Americans, or about 1% of the population, has celiac disease. Moreover, as per the University of Chicago Medicine's Celiac disease Center estimates - in USA Celiac disease affects at least 3 million Americans. Also, increasing investment in healthcare sector in developing region and rising R&D activities related to celiac disease drugs would create lucrative growth prospectus for the market over the forecast period. However, stringent regulatory framework for drug approval stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Celiac Disease Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and increasing incidences of celiac diseases in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and the growing healthcare sector in the region.

Major market players included in this report are:

• F. Hoffmann-La Roche
• Merck & Co., Inc.
• Johnson & Johnson
• BiolineRx Ltd.
• Pfizer Inc.
• Innovate Biopharmaceuticals
• ImmusanT, Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• Immunomedics, Inc.

Recent Developments in the Market:

• In August 2019, the US Food and Drug Administration (FDA) approved an investigational new drug (IND) for oral ActoBiotics AG017 capsules from ActoBio Therapeutics. This new drug is an oral biologic drug candidate for the reversal of celiac disease.

Global Celiac Disease Drugs Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Drugs, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drugs

• First Line of Treatment
• Second Line of Treatment

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Celiac Disease Drugs Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Celiac Disease Drugs Market, by Drugs, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Celiac Disease Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Celiac Disease Drugs Market Dynamics

• 3.1. Celiac Disease Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of Celiac Disease
    • 3.1.1.2. Growing investments in celiac disease awareness programs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Stringent regulatory framework for drug approval
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing investment in healthcare sector in developing region
    • 3.1.3.2. Rising R&D activities related to celiac disease drugs

Chapter 4. Global Celiac Disease Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Celiac Disease Drugs Market, by Drugs

• 6.1. Market Snapshot
• 6.2. Global Celiac Disease Drugs Market by Drugs, Performance - Potential Analysis
• 6.3. Global Celiac Disease Drugs Market Estimates & Forecasts by Drugs 2019-2029 (USD Billion)
• 6.4. Celiac Disease Drugs Market, Sub Segment Analysis
  • 6.4.1. First Line of Treatment
  • 6.4.2. Second Line of Treatment

Chapter 7. Global Celiac Disease Drugs Market, Regional Analysis

• 7.1. Celiac Disease Drugs Market, Regional Market Snapshot
• 7.2. North America Celiac Disease Drugs Market
  • 7.2.1. U.S. Celiac Disease Drugs Market
    • 7.2.1.1. Drugs breakdown estimates & forecasts, 2019-2029
  • 7.2.2. Canada Celiac Disease Drugs Market
• 7.3. Europe Celiac Disease Drugs Market Snapshot
  • 7.3.1. U.K. Celiac Disease Drugs Market
  • 7.3.2. Germany Celiac Disease Drugs Market
  • 7.3.3. France Celiac Disease Drugs Market
  • 7.3.4. Spain Celiac Disease Drugs Market
  • 7.3.5. Italy Celiac Disease Drugs Market
  • 7.3.6. Rest of Europe Celiac Disease Drugs Market
• 7.4. Asia-Pacific Celiac Disease Drugs Market Snapshot
  • 7.4.1. China Celiac Disease Drugs Market
  • 7.4.2. India Celiac Disease Drugs Market
  • 7.4.3. Japan Celiac Disease Drugs Market
  • 7.4.4. Australia Celiac Disease Drugs Market
  • 7.4.5. South Korea Celiac Disease Drugs Market
  • 7.4.6. Rest of Asia Pacific Celiac Disease Drugs Market
• 7.5. Latin America Celiac Disease Drugs Market Snapshot
  • 7.5.1. Brazil Celiac Disease Drugs Market
  • 7.5.2. Mexico Celiac Disease Drugs Market
  • 7.5.3. Rest of Latin America Celiac Disease Drugs Market
• 7.6. Rest of The World Celiac Disease Drugs Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. F. Hoffmann La Roche
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Merck & Co., Inc.
  • 8.2.3. Johnson & Johnson
  • 8.2.4. BiolineRx Ltd.
  • 8.2.5. Pfizer Inc.
  • 8.2.6. Innovate Biopharmaceuticals
  • 8.2.7. ImmusanT, Inc.
  • 8.2.8. Novartis AG
  • 8.2.9. Bristol-Myers Squibb Company
  • 8.2.10. Immunomedics, Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Celiac Disease Drugs Market, report scope
• TABLE 2. Global Celiac Disease Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Celiac Disease Drugs Market estimates & forecasts by Drugs 2019-2029 (USD Billion)
• TABLE 4. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 5. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. U.S. Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 16. U.S. Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. Canada Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. Canada Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. UK Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. UK Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. Germany Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. Germany Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. France Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. France Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. Italy Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. Italy Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Spain Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Spain Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. RoE Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. RoE Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. China Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. China Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. India Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. India Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. Japan Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. Japan Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. South Korea Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. South Korea Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. Australia Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. Australia Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. RoAPAC Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. Brazil Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. Brazil Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Mexico Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Mexico Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. RoLA Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. RoLA Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. Row Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. Row Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. List of secondary sources, used in the study of global Celiac Disease Drugs Market
• TABLE 69. List of primary sources, used in the study of global Celiac Disease Drugs Market
• TABLE 70. Years considered for the study
• TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Celiac Disease Drugs Market, research methodology
• FIG 2. Global Celiac Disease Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Celiac Disease Drugs Market, key trends 2021
• FIG 5. Global Celiac Disease Drugs Market, growth prospects 2022-2029
• FIG 6. Global Celiac Disease Drugs Market, porters 5 force model
• FIG 7. Global Celiac Disease Drugs Market, pest analysis
• FIG 8. Global Celiac Disease Drugs Market, value chain analysis
• FIG 9. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Celiac Disease Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Celiac Disease Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable